Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-25 Cream in CKD-associated Pruritus
2022-500044-38-00Phase 2Withdrawn
- Sponsor
- MC2 Therapeutics
- Start
- Jun 2022
- Modality
- Small Molecules, Peptides
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) comparing MC2-25 cream with Vehicle (placebo) cream (2 arms). Planned start Jun 2022; status: withdrawn.
02
Drugs
alanyl glutamine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2022-500044-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500044-38-00.